# Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer

> **NCT05052931** · PHASE2 · UNKNOWN · sponsor: **Jianjun Yang** · enrollment: 10 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Nab-paclitaxel combined with oxaliplatin and S-1

## Key facts

- **NCT ID:** NCT05052931
- **Lead sponsor:** Jianjun Yang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05052931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05052931, "Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05052931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*